| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Common Stock | +Options Exercise | $886,289 | +22,415 | +23.06% | $39.54 | 119,616 | Feb 13, 2024 | Direct | |
| transaction | CBT | Common Stock | -Sell | -$1,779,303 | -22,415 | -18.74% | $79.38 | 97,201 | Feb 13, 2024 | Direct | F1 |
| transaction | CBT | Common Stock | +Options Exercise | $728,340 | +14,434 | +14.85% | $50.46 | 111,635 | Feb 13, 2024 | Direct | |
| transaction | CBT | Common Stock | -Sell | -$1,154,720 | -14,434 | -12.93% | $80.00 | 97,201 | Feb 13, 2024 | Direct | |
| transaction | CBT | Common Stock | +Options Exercise | $1,144,220 | +18,384 | +18.91% | $62.24 | 115,585 | Feb 13, 2024 | Direct | |
| transaction | CBT | Common Stock | -Sell | -$1,479,912 | -18,384 | -15.91% | $80.50 | 97,201 | Feb 13, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Employee Stock Option (Right to Buy) | -Options Exercise | $0 | -22,415 | -100% | $0.00 | 0 | Feb 13, 2024 | Common Stock | 22,415 | $39.54 | Direct | F2 |
| transaction | CBT | Employee Stock Option (Right to Buy) | -Options Exercise | $0 | -14,434 | -100% | $0.00 | 0 | Feb 13, 2024 | Common Stock | 14,434 | $50.46 | Direct | F3 |
| transaction | CBT | Employee Stock Option (Right to Buy) | -Options Exercise | $0 | -18,384 | -100% | $0.00 | 0 | Feb 13, 2024 | Common Stock | 18,384 | $62.24 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.340 - $79.670, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F2 | 22,415 shares were subject to the option. The option vested over a three year period as follows: 30% on November 12, 2016, 30% on November 12, 2017 and 40% on November 12, 2018. |
| F3 | 20,620 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2017, 30% on November 11, 2018 and 40% on November 11, 2019. |
| F4 | 18,384 shares were subject to the option. The option vested over a three year period as follows: 30% on November 10, 2018, 30% on November 10, 2019 and 40% on November 10, 2020. |